
Keywords: گیرنده عامل رشد; EORTC; European Organisation for Research and Treatment of Cancer; FDA; Food and Drug Administration; GBM; glioblastoma multiforme; GFR; growth factor receptor; IDH; isocitrate dehydrogenase gene; KPS; Karnofsky Performance Status; MGMT; O6-methylguanine-